Characterization of negatively charged phospholipids and cell origin of microparticles in women with gestational vascular complications

Thrombosis Research

Volumn 130, Issue 3, 2012, Pages 479-484

  Katzenell, Sarah ^a,b   Shomer, Einat ^a,b   Zipori, Yaniv ^c   Zylberfisz, Andres ^d   Brenner, Benjamin ^a,b   Aharon, Anat ^a,b  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b RAMBAM MEDICAL CENTER   (Israel)

^c Bnai Zion Medical Center ^*  (Israel)

^d BNAI ZION MEDICAL CENTER   (Israel)

Author keywords

Gestational vascular complications (GVC); Hypertension; Low molecular weight heparin (LMWH); Microparticles (MPs); Negativly charge phospholipides; Preeclampsia toxemia

Indexed keywords

ACETYLSALICYLIC ACID; CD31 ANTIGEN; ENOXAPARIN; PHOSPHOLIPID; VASCULAR ENDOTHELIAL CADHERIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; GESTATIONAL AGE; HUMAN; HUMAN CELL; LEUKOCYTE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; MEMBRANE MICROPARTICLE; PREECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOCYTE; THROMBOPHILIA; THROMBOSIS; TROPHOBLAST;

ADULT; ANIONS; CELL-DERIVED MICROPARTICLES; FEMALE; HUMANS; PHOSPHOLIPIDS; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; STATIC ELECTRICITY; VASCULAR DISEASES;

EID: 84865266022     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2012.03.026     Document Type: Article

References (37)

1. V.J. Karthikeyan, and G.Y. Lip Endothelial damage/dysfunction and hypertension in pregnancy Front Biosci (Elite Ed) 3 2011 1100 1108
2. J. Uzan, M. Carbonnel, O. Piconne, R. Asmar, and J.M. Ayoubi Pre-eclampsia: pathophysiology, diagnosis, and management Vasc Health Risk Manag 7 2011 467 474
3. M. Kupferminc, E. Rimon, A. Many, S. Maslovitz, J.B. Lessing, and R. Gamzu Low molecular weight heparin versus no treatment in women with previous severe pregnancy complications and placental findings without thrombophilia Blood Coagul Fibrinolysis 22 2011 123 126
4. J.C. Gris, C. Chauleur, J.L. Faillie, G. Baer, P. Mares, and P. Fabbro-Peray Enoxaparin for the secondary prevention of placental vascular complications in women with abruptio placentae. The pilot randomised controlled NOH-AP trial Thromb Haemost 104 2010 771 779
5. A. Piccin, W.G. Murphy, and O.P. Smith Circulating microparticles: pathophysiology and clinical implications Blood Rev 21 2007 157 171
6. O. Morel, L. Jesel, J.M. Freyssinet, and F. Toti Cellular mechanisms underlying the formation of circulating microparticles Arterioscler Thromb Vasc Biol 31 2011 15 26
7. O. Salomon, B.Z. Katz, R. Dardik, T. Livnat, D.M. Steinberg, and R. Achiron Plasma levels of microparticles at 24 weeks of gestation do not predict subsequent pregnancy complications Fertil Steril 92 2009 682 687
8. H. Carp, R. Dardik, A. Lubetsky, O. Salomon, R. Eskaraev, and E. Rosenthal Prevalence of circulating procoagulant microparticles in women with recurrent miscarriage: a case-controlled study Hum Reprod 19 2004 191 195
9. A. Aharon, and B. Brenner Microparticles and pregnancy complications Thromb Res 127 Suppl. 3 2011 S67 S71
10. E. van der Pol, A.G. Hoekstra, A. Sturk, C. Otto, T.G. van Leeuwen, and R. Nieuwland Optical and non-optical methods for detection and characterization of microparticles and exosomes J Thromb Haemost 8 2010 2596 2607
11. R. Lacroix, S. Robert, P. Poncelet, R.S. Kasthuri, N.S. Key, and F. Dignat-George Standardization of platelet-derived microparticle enumeration by flow cytometry with calibrated beads: results of the International Society on Thrombosis and Haemostasis SSC Collaborative workshop J Thromb Haemost 8 2010 2571 2574
12. B. Gyorgy, K. Modos, E. Pallinger, K. Paloczi, M. Pasztoi, and P. Misjak Detection and isolation of cell-derived microparticles are compromised by protein complexes resulting from shared biophysical parameters Blood 117 2011 e39 e48
13. J. Alijotas-Reig, C. Palacio-Garcia, I. Farran-Codina, M. Ruiz-Romance, E. Llurba, and M. Vilardell-Tarres Circulating Cell-Derived Microparticles in Severe Preeclampsia and in Fetal Growth Restriction Am J Reprod Immunol 67 2012 140 151
14. B. Brenner Clinical management of thrombophilia-related placental vascular complications Blood 103 2004 4003 4009
15. G. Sarig, G. Vidergor, and B. Brenner Assessment and management of high-risk pregnancies in women with thrombophilia Blood Rev 23 2009 143 147
16. F. Dignat-George, and C.M. Boulanger The many faces of endothelial microparticles Arterioscler Thromb Vasc Biol 31 2011 27 33
17. J.C. Williams, and N. Mackman MPs or ICs? Blood 117 2011 1101 1102
18. M.C. Valera, O. Parant, C. Vayssiere, J.F. Arnal, and B. Payrastre Physiologic and pathologic changes of platelets in pregnancy Platelets 21 2010 587 595
19. M.T. Peracoli, F.T. Menegon, V.T. Borges, R.A. de Araujo Costa, I.A. Thomazini-Santos, and J.C. Peracoli Platelet aggregation and TGF-beta(1) plasma levels in pregnant women with preeclampsia J Reprod Immunol 79 2008 79 84
20. C.A. Lok, R. Nieuwland, A. Sturk, C.M. Hau, K. Boer, and E. Vanbavel Microparticle-associated P-selectin reflects platelet activation in preeclampsia Platelets 18 2007 68 72
21. M.G. Macey, S. Bevan, S. Alam, L. Verghese, S. Agrawal, and S. Beski Platelet activation and endogenous thrombin potential in pre-eclampsia Thromb Res 125 2010 e76 e81
22. J. Villar, G. Carroli, D. Wojdyla, E. Abalos, D. Giordano, and H. Ba'aqeel Preeclampsia, gestational hypertension and intrauterine growth restriction, related or independent conditions? Am J Obstet Gynecol 194 2006 921 931
23. V.H. Gonzalez-Quintero, L.P. Smarkusky, J.J. Jimenez, L.M. Mauro, W. Jy, and L.L. Hortsman Elevated plasma endothelial microparticles: preeclampsia versus gestational hypertension Am J Obstet Gynecol 191 2004 1418 1424
24. A. Aharon, S. Katzenell, T. Tamari, and B. Brenner Microparticles bearing tissue factor and tissue factor pathway inhibitor in gestational vascular complications J Thromb Haemost 7 2009 1047 1050
25. C.A. Lok, J. Jebbink, R. Nieuwland, M.M. Faas, K. Boer, and A. Sturk Leukocyte activation and circulating leukocyte-derived microparticles in preeclampsia Am J Reprod Immunol 61 2009 346 359
26. L.L. Horstman, W. Jy, J.J. Jimenez, and Y.S. Ahn Endothelial microparticles as markers of endothelial dysfunction Front Biosci 9 2004 1118 1135
27. J. Kwak-Kim, K.M. Yang, and A. Gilman-Sachs Recurrent pregnancy loss: a disease of inflammation and coagulation J Obstet Gynaecol Res 35 2009 609 622
28. B. Brenner Enoxaparin use in pregnancy: state of the art Womens Health (Lond Engl) 3 2007 9 14
29. J.H. Rand, X.X. Wu, S. Guller, J. Gil, A. Guha, and J. Scher Reduction of annexin-V (placental anticoagulant protein-I) on placental villi of women with antiphospholipid antibodies and recurrent spontaneous abortion Am J Obstet Gynecol 171 1994 1566 1572
30. J. Thaler, C. Ay, H. Weinstabl, D. Dunkler, R. Simanek, and R. Vormittag Circulating procoagulant microparticles in cancer patients Ann Hematol 90 2011 447 453
31. M. Bernimoulin, E.K. Waters, M. Foy, B.M. Steele, M. Sullivan, and H. Falet Differential stimulation of monocytic cells results in distinct populations of microparticles J Thromb Haemost 7 2009 1019 1028
32. S. Perez-Pujol, P.H. Marker, and N.S. Key Platelet microparticles are heterogeneous and highly dependent on the activation mechanism: studies using a new digital flow cytometer Cytometry A 71 2007 38 45
33. F. Bretelle, F. Sabatier, D. Desprez, L. Camoin, L. Grunebaum, and V. Combes Circulating microparticles: a marker of procoagulant state in normal pregnancy and pregnancy complicated by preeclampsia or intrauterine growth restriction Thromb Haemost 89 2003 486 492
34. F. Meziani, A. Tesse, E. David, M.C. Martinez, R. Wangesteen, and F. Schneider Shed membrane particles from preeclamptic women generate vascular wall inflammation and blunt vascular contractility Am J Pathol 169 2006 1473 1483
35. M.J. VanWijk, R. Nieuwland, K. Boer, J.A. van der Post, E. VanBavel, and A. Sturk Microparticle subpopulations are increased in preeclampsia: possible involvement in vascular dysfunction? Am J Obstet Gynecol 187 2002 450 456
36. C.M. Boulanger, N. Amabile, and A. Tedgui Circulating microparticles: a potential prognostic marker for atherosclerotic vascular disease Hypertension 48 2006 180 186
37. D.L. Daleke Regulation of transbilayer plasma membrane phospholipid asymmetry J Lipid Res 44 2003 233 242